XML 435 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-based compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Schedule of Share-Based Payment Arrangement By Share-Based Payment Award, Performance Criteria The table below shows the performance criteria and the corresponding weight of the LTI performance plans granted
in 2023.
LTI performance plan criteria
Market/Non-Market element
Weight
Relative TSR
Market
30%
Strategic value drivers
Non-Market
30%
Technology Leadership Index
Non-Market
20%
ESG Measures
Non-Market
20%
Total
100%
Schedule of Assumptions Used for Calculation of the Fair Value of Shares The most important assumptions for the calculation of the fair value of shares for the LTI performance plans, which
include a market-based performance criteria, are set out in the following table:
Year ended December 31
2021
2022
2023
Share price in € at grant date
462.9
548.0
620.1
Expected volatility ASML
38.5%
41.8%
46.2%
Expected volatility PHLX index
35.3%
n/a
n/a
Average volatility of the peer group (market practice)
n/a
47.8%
50.0%
Vesting period
2.9 years
2.7 years
2.9 years
Dividend yield
0.6%
1.0%
0.9%
Risk free interest rate (Eurozone)
(0.8)%
0.5%
2.4%
Risk free interest rate (US)
0.2%
2.8%
3.9%
Schedule of Expenses for Share Plans Expenses for LTI plans, including the Board of Management, were as follows:
Year ended December 31 (€, in millions)
2021
2022
2023
Total incurred expenses
117.5
68.9
134.8
Recognized income tax benefit (excluding excess income tax benefits)
8.2
10.2
16.3
Total expected expenses in future periods
125.4
113.0
187.2
Weighted average period in which these expected expenses are to be
recognized
1.7 years
1.4 years
1.6 years
Schedule of Shares Activity During Period Details with respect to shares granted and vested during the year are set out in the following table:
  
EUR-denominated
USD-denominated
Year ended December 31
2021
2022
2023
2021
2022
2023
Total fair value at vesting date of shares vested during the year
(in millions)
156.9
120.6
175.5
164.0
149.6
127.0
Weighted average fair value of shares granted
547.79
578.65
587.42
498.64
553.61
624.10
A summary of the status of conditionally outstanding shares as of December 31, 2023, and changes during the year
ended December 31, 2023, is presented below:
  
EUR-denominated
USD-denominated
 
Number
of shares
Weighted
average
fair value at
grant date
Number
of shares
Weighted
average
fair value at
grant date
Conditional shares outstanding at January 1, 2023
292,765
434.10
238,394
542.22
Granted
244,069
587.42
295,235
624.10
Vested
(257,451)
425.34
(167,746)
515.96
Forfeited
(3,812)
557.77
(2,764)
622.98
Conditional shares outstanding at December 31, 2023
275,571
576.37
363,119
620.31
Details with respect to stock options exercised and outstanding are set out in the following table:
  
EUR-denominated
USD-denominated
Year ended December 31
2021
2022
2023
2021
2022
2023
Weighted average share price at the exercise date of stock options
583.33
494.14
613.03
658.16
565.39
678.41
Aggregate intrinsic value of stock options exercised (in millions)
5.7
4.4
8.1
4.1
1.6
4.8
Weighted average remaining contractual term of currently
exercisable options (in years)
2.81
2.08
1.48
2.93
2.09
1.43
Aggregate intrinsic value of exercisable stock options (in millions)
36.7
20.3
19.7
24.9
14.6
15.9
Aggregate intrinsic value of outstanding stock options (in millions)
36.7
20.3
19.7
24.9
14.6
15.9
Schedule of Number and Weighted Average Exercise Prices of Stock Options Activity The number and weighted average exercise prices of stock options as of December 31, 2023, and changes during
the year then ended are presented below:
  
 EUR-denominated
USD-denominated
 
Number
of options
Weighted
average
exercise price
per ordinary
share (EUR)
Number
of options
Weighted
average
exercise price
per ordinary
share (USD)
Outstanding, January 1, 2023
47,607
77.95
32,138
92.84
Granted1
Exercised
(14,768)
67.80
(8,175)
89.40
Forfeited
Expired
(1)
92.23
Outstanding, December 31, 2023
32,839
82.52
23,962
94.01
Exercisable, December 31, 2023
32,839
82.52
23,962
94.01
1.Since 2017, we no longer grant options to our employees.
Schedule of Range of Exercise Prices, Number of Outstanding Options, and Weighted Average Remaining Contractual Life of Oustanding Options Details with respect to stock options exercised in the relevant year and outstanding stock options as of December
31, 2023, are set out in the following table:
EUR-denominated
USD-denominated
Range of exercise
prices (€)
Number of
outstanding options
Weighted average
remaining
contractual life of
outstanding (years)
Range of exercise
prices (USD)
Number of
outstanding options
Weighted average
remaining
contractual life of
outstanding (years)
5060
1,936
0.30
5060
0.00
6070
2,457
0.31
6070
0.00
7080
8,444
1.34
7080
0.00
8090
9,966
1.84
8090
7,569
0.97
90100
10,036
1.75
90100
10,087
1.59
100110
0.00
100110
6,306
1.73
Total
32,839
1.48
Total
23,962
1.43